| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6b5fdc4a4aa99406964e50f5129469d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-28 |
| filingDate |
2018-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01d05bedf731a371dceb68e74e228f8 |
| publicationDate |
2020-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111801314-A |
| titleOfInvention |
ASK1 inhibitor compounds and uses thereof |
| abstract |
Described herein are compounds, including pharmaceutically acceptable salts and solvates thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds, and use of such compounds for the treatment of nonalcoholic steatohepatitis and other disorders of the function Methods of tissue healing and fibrosis-characterized diseases. |
| priorityDate |
2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |